Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CRHBP | P24387 | 1/20 | 0.31 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14610355 | 0.85 | MEN1 (0.40) | MAPTLMNANPC1POLBRAB9A | |
| SCHEMBL16478895 | 0.85 | MEN1 (0.40) | MAPTLMNANPC1POLBRAB9A | |
| SCHEMBL19486638 | 0.83 | — | — | |
| SCHEMBL14095020 | 0.78 | — | — | |
| SCHEMBL14471368 | 0.74 | ALDH1A1 (0.33) | MAPTLMNANPC1POLBRAB9A | |
| SCHEMBL16473140 | 0.72 | — | — | |
| SCHEMBL17445954 | 0.69 | MAPT (0.55) | MAPTLMNANPC1POLBRAB9A | |
| SCHEMBL13485630 | 0.66 | ALDH1A1 (0.33) | MAPTLMNANPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL18959154 | 0.62 | MAPT (0.35) | MAPTLMNANPC1POLBRAB9A | |
| SCHEMBL12101244 | 0.61 | MEN1 (0.38) | MAPTLMNAPOLBALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080095967-A1 | Optical Recording Materials Having High Storage Density | KUNIMOTO KAZUHIKO | 2008-04-24 | — | — | US | disclosed |
| US-20070184232-A1 | Optical recording materials having high storage density | CIBA SPECIALTY CHEMICALS CORP. | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080095967-A1 | Optical Recording Materials Having High Storage Density | CRY2, RPS21, CRY1 | MAPT 435/4885LMNA 1242/4885NPC1 3984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.